Evidence map›Paper›PMID 42653776›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Manyu Wang, Yang Fu, Peipei Yuan, Yi Zeng, Zihao Yang, Shenggui Zhang, Weisheng Feng, Xiaoke Zheng

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manyu WangDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Yang FuDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.ORCID 0000-0002-4430-8301
Peipei YuanDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Yi ZengDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Zihao YangDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Shenggui ZhangDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Weisheng FengDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.ORCID 0000-0002-5987-412X
Xiaoke ZhengDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.

Funding

the 2024 Postgraduate Research Innovation Capacity Improvement Pro-gram 2024KYCX026the Henan Province Double First-Class Initiative Fund - High-Level Talent Introduction Program 00104311-2023-81the National Key Research and Development Program (Major Project for Research of the Modernization of TCM 2019YFC1708802
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

doxorubicinGnRH signaling pathwaymeiosisRadix Bupleuri Chinensis extractspermatogenic dysfunctiontaurine

Identifiers

PMID42653776
PMCPMC13516573

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.